SPARTANBURG, S.C. (August 15, 2019)—QS/1, a pharmacy operating system provider and innovator, is excited to announce a partnership with Therigy, the trusted partner in specialty pharmacy software, consulting and outcomes, to improve specialty pharmacy operations between their dispensing system and therapy management software. Specialty pharmacy is the fastest-growing area within the industry and can help pharmacies increase their patient base as well as diversify their business. The ability to tap into TherigySTM will help pharmacies simplify the patient care process to better serve and improve patient outcomes.
“Therigy is widely known for its patient-centric specialty therapy management technology,” said Ed Vess, R.Ph, QS/1’s director of pharmacy professional affairs. “This partnership between our two organizations will give QS/1’s pharmacy customers access to cutting-edge services, allowing them to automate, streamline and focus on patient management.”
TherigySTM technologies offer a range of resources that give pharmacists the tools required for detailed tracking of patient progress with specialty medications. Combined with QS/1’s NRx pharmacy management system, the interface with TherigySTM helps pharmacies minimize duplicate data entry and improve workflow by tracking dispenses, managing patient’s care, reporting on outcomes, and running required reports.
“Therigy is excited for this opportunity to team up with QS/1 in this effort,” said Joseph Morse, CEO of Therigy. “Through this integration, TherigySTM can electronically receive patient information from QS/1’s systems and automatically populate many of the fields required during the patient onboarding process, giving customers the ability to focus on better care for their patients.”
“Dispensing specialty medications offers revenue potential for community pharmacies,” Vess added. “Pharmacists can quickly realize the investment benefits and ultimately increase their profits. We think it is another way community pharmacy can set itself apart from other pharmacy markets that lack that personal touch patients deserve, which has a direct effect on patient adherence.”
Visit qs1.com for more information.
